Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Part of Sekisui Chemical Co., Ltd., Sekisui Medical Co., Ltd. is a Japanese company located in Tokyo that manufactures and markets in-vitro diagnostic substances and pharmaceutical products. It was acquired by Sekisui Chemical Co., Ltd. from Daiichi Sankyo Co., Ltd. on October 02, 2006.

Harbin Pharmaceutical Group Pharmaceutical Factory, established on 1994-05-19, Business scope includes<Pharmaceutical Production License>,<food production license>,<Special license for monitoring chemical production>,<Grain Purchase License>Approved scope to develop drugs,Health food production and grain purchase business activities;Pharmaceutical and related equipment and raw materials,Organic Chemical Raw Materials(Free of Hazardous Chemicals),Production of Medical Devices,Production of labor insurance products,Production and sales of household chemicals;Paper Products Manufacturing,Sanitary Products Sales;foreign trade;Purchase and sale of pharmaceutical raw materials and equipment,disinfection products,biological organic matter;Weak current engineering design and construction;Information system integration service;Software and information system operation and maintenance services;Special Equipment Repair;Inspection and testing service.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Sanyo Fine Co. Ltd., a subsidiary of OSAKA SODA CO., LTD., is a Japanese company located in Osaka. The firm produces bio-chemical products. On December 16, 2008 OSAKA SODA CO., LTD. acquired Sanyo Fine Co. Ltd.

Global Summit Real Estate, Inc. provides real estate management services. The company was founded on October 1, 2005 and is headquartered in Vancouver, Canada.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Nippon Chemiphar Co., Ltd. engages in the healthcare business. It manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents. It operates through the Pharmaceuticals and Others segments. The Pharmaceuticals segment manufactures and sells prescription drugs. The Others segment includes safety testing consignment, healthcare, and real estate businesses. The company was founded by Akira Yamaguchi on June 16, 1950 and is headquartered in Tokyo, Japan.

Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to produce new ones as leads for drug discovery or as products for use in industry, and to identify drug targets in fungi for antifungal drug discovery. In 2002 the company hired John Talley to lead their antifungal drug discovery efforts, which at the time were focused on identifying small molecules that could inhibit fungal invasins, along with Mark Currie who had also worked at Searle division of Monsanto with Talley, and then had gone to Sepracor, and also Richard Bailey, who had run Monsanto's nutritional business. Currie directed the efforts that led to the discovery of linaclotide, which was based on an enterotoxin produced by some strains of Escherichia coli that cause traveler’s diarrhea.

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

Guangzhou Aiqixi Pharmaceutical Technology Co., Ltd., established on 2011-01-31, Business scope includes engineering and technology research and experimental development;Medical Research and Experimental Development;R&D of industrial enzyme preparations;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical equipment rental;Health Consulting Services(Does not include medical services);business management;Cosmetics Retail;Sales of hygiene products and single-use medical products;Conference and Exhibition Services;Computer and communication equipment rental;Machinery and Equipment Leasing;Office equipment rental service;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);synthetic material manufacturing(Free of Hazardous Chemicals);pharmaceutical production;Drug Wholesale;Drug import and export;Import and export;Technology Import and Export

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Human Metabolome Technologies, Inc. engages in the business of diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients. The Biomarker segment deals with the development of biomarker license in collaboration with the group companies. The Temporary Staffing segment provides researchers and technicians. The company was founded by Yoshihiro Otaki, Masaru Tomita, and Tomoyoshi Soga on July 1, 2003 and is headquartered in Tsuruoka, Japan.

SalivaTech is a new screening development business and saliva test that allows self-health care to detect and treat cancer early.

NHC Communications, Inc. manufactures network switching and test equipment for local telecom service providers, corporations and multi-tenant buildings. It also offers the XPoint product line geared for smaller network applications. The company was founded in 1986 and is headquartered in Mount-Royal, Canada

Part of Novartis AG, Biochemie GmbH is an Austrian company located in Kundl specializing in pharmaceutical preparations.